News Now

FSSAI Suspends License of Rehaan Healthcare Over Severe Food Safety Violations

The Food Safety and Standards Authority of India (FSSAI) has suspended the manufacturing license of Rehaan Healthcare with immediate effect following critical non-compliances discovered during an inspection of its Health Supplements...

From Laboratory to Patients: ICMR’s Indigenous Biomedical Technologies Move Towards Commercialization

In a significant milestone for India's biomedical innovation ecosystem, the Indian Council of Medical Research (ICMR) has formally...

CISCE Makes Health and Physical Education Compulsory for Classes 9 to 12 Under NEP 2020

The Council for the Indian School Certificate Examinations (CISCE) has announced that Health and Physical Education is now...

Momentis Surgical’s Anovo Robotic System Gets FDA Approval for Multiport Surgery

Momentis Surgical has secured 510(k) clearance from the U.S. Food and Drug Administration for a multiport version of its Anovo Surgical...

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Adani Group to Build ₹2,500 Crore ‘Adani Arogya Mandir’ Health City in Kolkata in Collaboration with Mayo Clinic

The Adani Group has received government approval to establish a state-of-the-art health city, named Adani Arogya Mandir, in New Town, Kolkata. Representing a monumental investment of...

Aster DM Healthcare India and Quality Care India Limited joins force to Create ‘Aster DM Quality Care Ltd.’

Aster DM Healthcare India and Quality Care India Limited have officially combined forces to establish Aster DM Quality Care Ltd., instantly creating one of...

Novartis Receives European Commission Approval for Itvisma®️ for older patient with spinal muscular atrophy

Novartis announced that the European Commission has approved Itvisma® (onasemnogene abeparvovec) for the treatment of 5q spinal muscular atrophy (SMA) with a bi-allelic mutation...

Enhertu Becomes First HER2 Tumour-Agnostic Therapy Approved in Europe for solid tumours

AstraZeneca and Daiichi Sankyo  announced that the European Commission has approved Enhertu (trastuzumab deruxtecan) as a monotherapy for adult patients with unresectable or metastatic HER2-positive (IHC 3+) solid tumours...

Alembic’s New Gujarat Hub to Speed Up Medicine Supply

Alembic Pharmaceuticals Limited has marked a significant step forward in its logistics infrastructure with the launch of a new Central Stock Point (CSP) in Kheda,...

Union Health Minister Reviews Dengue Preparedness in Delhi

Union Health and Family Welfare Minister Shri J.P. Nadda convened a high-level meeting on July 1, 2026, to evaluate Delhi's readiness for the dengue season. Officials...